Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non-small Cell Lung Cancer × Carboplatin × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 65 Lung Neoplasms 33 Squamous Cell Carcinoma of Head and Neck 18 Small Cell Lung Carcinoma 12 Ovarian Neoplasms 12 Breast Neoplasms 12 Triple Negative Breast Neoplasms 11 Fallopian Tube Neoplasms 11 Endometrial Neoplasms 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Neoplasms 10 Colorectal Neoplasms 9 Neoplasm Metastasis 8 Carcinoma 8 Head and Neck Neoplasms 7 Oropharyngeal Neoplasms 6 Laryngeal Neoplasms 6 Esophageal Neoplasms 6 Uterine Cervical Neoplasms 5 Mouth Neoplasms 5 Carcinoma, Transitional Cell 5 Carcinoma, Squamous Cell 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Thoracic Neoplasms 3 Salivary Gland Neoplasms 3

Interventions

pembrolizumab 1 Pemetrexed 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06452277 2026-03-02

SOHO-02

Bayer

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡